Indeed, changes in glutamatergic GluA1 AMPA receptor subunits and GFAP (reduction), or increased PSD95 levels might represent an important aspect to the dynamic allostasis of excitability of neuroglial circuits under the influence of CBD. The gene discussed is GFAP; the disease is red-green color blindness.